Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSareum Share News (SAR)

Share Price Information for Sareum (SAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.50
Bid: 33.00
Ask: 34.00
Change: 1.00 (3.08%)
Spread: 1.00 (3.03%)
Open: 32.50
High: 35.50
Low: 32.50
Prev. Close: 32.50
SAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Shareholder Meetings Calendar - Next 7 Days

Tue, 11th Dec 2018 15:55

Wednesday 12 December
Blancco Technology Group
Bellway
Volution Group
Tristel
Yougov
Netcall
Imaginatik
Bowleven
Local Shopping REIT (re voluntary liquidation)
Thursday 13 December
Nanoco Group
Amur Minerals
Fidelity Asian Values
Friday 14 December
Northamber
Botswana Diamonds
UP Global Sourcing Holdings 
Flybe Group (re transfer from Premium listing to Standard listing)
Monday 17 December
Edinburgh Dragon IT
Tuesday 18 December
Applied Graphene Materials
Dotdigital
Sareum Holdings
Schroder Income Growth Fund
 

More News
7 Oct 2021 22:08

TRADING UPDATES: Marlowe buys; Galliford snaps up nmcn's Water unit

TRADING UPDATES: Marlowe buys; Galliford snaps up nmcn's Water unit

Read more
19 Aug 2021 14:25

IN BRIEF: Sareum expects annual loss to widen, increases R&D

IN BRIEF: Sareum expects annual loss to widen, increases R&D

Read more
19 Aug 2021 07:41

Sareum expects FY losses to widen on higher R&D costs, supply delays

(Sharecast News) - British drugmaker Sareum said on Thursday that it expects to post a widened full-year loss as a result of increased research-and-development expenditure and delays in compound supply.

Read more
9 Aug 2021 17:08

TRADING UPDATES: Netcall wins new deal; Sareum raises GBP1 million

TRADING UPDATES: Netcall wins new deal; Sareum raises GBP1 million

Read more
6 Aug 2021 15:00

Sareum positive on SRA737 outlook after Sierra call

(Sharecast News) - Specialist drug development company Sareum noted on Friday that Sierra Oncology, the licence holder for the novel Chk1 inhibitor 'SRA737', had discussed its newly-announced global in-licensing agreement with AstraZeneca for AZD5153 with investors, which is a novel BRD4 BET inhibitor, to expand its myelofibrosis pipeline.

Read more
30 Jul 2021 19:40

TRADING UPDATES: Capita and Custodian REIT agree disposals

TRADING UPDATES: Capita and Custodian REIT agree disposals

Read more
30 Jul 2021 11:00

AIM WINNERS & LOSERS: Sareum in patent boost; Airea flags uncertainty

AIM WINNERS & LOSERS: Sareum in patent boost; Airea flags uncertainty

Read more
19 Jul 2021 19:13

TRADING UPDATES: Sareum raises GBP1 million; Marlowe buys Core Stream

TRADING UPDATES: Sareum raises GBP1 million; Marlowe buys Core Stream

Read more
1 Jul 2021 19:26

TRADING UPDATES: Gym Group bulks up with placing; 88 Energy debt free

TRADING UPDATES: Gym Group bulks up with placing; 88 Energy debt free

Read more
1 Jul 2021 11:18

Sareum releases 'encouraging' results from Covid-19 research

(Sharecast News) - Specialist drug development company Sareum announced "encouraging" top-line results from its UKRI grant-funded Covid-19 research project on Thursday.

Read more
15 Jun 2021 20:28

TRADING UPDATES: Tremor Nasdaq IPO underway; MGC's CannEpil in Ireland

TRADING UPDATES: Tremor Nasdaq IPO underway; MGC's CannEpil in Ireland

Read more
1 Jun 2021 17:43

TRADING UPDATES: Breedon buys Micromix; Marlowe acquires Alarm

TRADING UPDATES: Breedon buys Micromix; Marlowe acquires Alarm

Read more
1 Jun 2021 11:30

AIM WINNERS & LOSERS: Sound Energy falls on Morocco tax notification

AIM WINNERS & LOSERS: Sound Energy falls on Morocco tax notification

Read more
25 May 2021 17:11

TRADING UPDATES: Mothercare sales down; Revolution Bars seeks to raise

TRADING UPDATES: Mothercare sales down; Revolution Bars seeks to raise

Read more
25 May 2021 10:56

Sareum's pre-clinical development of SDC-1801 delayed by Covid-19

(Sharecast News) - Pharmaceutical company Sareum said on Tuesday that Covid-19 has continued to impact the contract research organisations it was working to complete pre-clinical development of its SDC-1801 drug candidate for autoimmune disease.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.